Register
Login:
Share:
Email Facebook Twitter


EXCLUSIVE: Alastair Smith, Avacta Group CEO gives an Operational Update


Skinbiotherap. Share Price (SBTX)



Share Price Information for Skinbiotherap. (SBTX)


Share Price: 21.00Bid: 20.50Ask: 21.50Change: 0.00 (0.00%)No Movement on Skinbiotherap.
Spread: 1.00Spread as %: 4.88%Open: 21.50High: 21.50Low: 20.00Yesterday’s Close: 21.00

Skinbiotherapeutics Plc Ord 1P

Skinbiotherap. is part of the Medicine and Biotech Research sector






Share Price SpacerPrice
21.00
Share Price SpacerBid
20.50
Share Price SpacerAsk
21.50
Share Price SpacerChange
0%0.00
Share Price SpacerVolume
422,679
Share Price SpacerOpen
21.50
Share Price SpacerHigh
21.50
Share Price SpacerLow
20.00
Share Price SpacerClose
21.00
Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 118.71m £24.93m 10,000

52 Week High 29.50 52 Week High Date 17-SEP-2018
52 Week Low 7.35 52 Week Low Date 22-FEB-2018

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
22 158,391 21,775 -18.919 -1.11 0.00 0.00




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

20-Sep-18
17:05:57
21.00
5,000
 
20.50
21.50
1,050
Trade Type:
Ordinary

20-Sep-18
14:46:12
21.425
2,191
Buy* 
20.00
21.50
469.42
Trade Type:
Ordinary

20-Sep-18
11:10:35
20.752
71,800
Buy* 
20.00
21.50
14.90k
Trade Type:
Ordinary
Delayed publication




View more Skinbiotherap. trades >>

Directors Deals for Skinbiotherap. (SBTX)
Trade DateActionNotifierPriceCurrencyAmountHolding
30-Mar-17Notification of Holding
Trade Notifier Information for SkinBioTherapeutics
Catherine Anne O'Neil held the position of CEO at SkinBioTherapeutics at the time of this trade.
 Catherine Anne O'Neil
005256989
30-Mar-17Notification of Holding
Trade Notifier Information for SkinBioTherapeutics
Martin Braddock Hunt held the position of Non-Executive Chairman at SkinBioTherapeutics at the time of this trade.
 Martin Braddock Hunt
00444444
30-Mar-17Notification of Holding
Trade Notifier Information for SkinBioTherapeutics
Douglas John Quinn held the position of CFO at SkinBioTherapeutics at the time of this trade.
 Douglas John Quinn
00444444
View more Skinbiotherap. directors dealings >>


Sheephatch
Posts: 1,304
Opinion:Strong Buy
Price:21.50
RNS
Wed 11:36
Informative and concise. Dates all set out so I think the slight drop is just down to a inpatient investors. I'm personally very happy we have a timetable laid out. With good news on all stages this should have a much higher SP from today's prices and in multiple terns down the road. Good luck.
manksy
Posts: 170
Opinion:No Opinion
Price:21.00
RE: that's a sustantial retrace
Wed 08:59
Can only assume today's RNS is the answer - pushing out test 3 on barrier is the key to much of the technology being extended for other uses. This has obviouslydisappointed folks. Test one - is a given already or else all is lost. test two moisture will certiainly be good news in cosmetics but a pretty busy market space to break into. Conspiracy this news affected teh price yesterday before release. GL all.
manksy
Posts: 170
Opinion:No Opinion
Price:21.00
RE: that's a sustantial retrace
Wed 08:59
Can only assume today's RNS is the answer - pushing out test 3 on barrier is the key to much of the technology being extended for other uses. This has obviouslydisappointed folks. Test one - is a given already or else all is lost. test two moisture will certiainly be good news in cosmetics but a pretty busy market space to break into. Conspiracy this news affected teh price yesterday before release. GL all.
Sotolo
Posts: 436
Opinion:No Opinion
Price:21.00
RE: that's a sustantial retrace
Wed 08:58
Not sure, was that a double top we saw day before yesterday?
Or will it turn back up and break through the high?
Trader4Pay
Posts: 93
Opinion:No Opinion
Price:23.25
RE: that's a sustantial retrace
Wed 00:49
Chart looks good currently. News soon so may drift until then but there is interest and believe there are folks on the side lines waiting for a good entry. Medium to long term if the formula/cream does what they say then there is a product. And if the medical creams help with symptoms well that just adds more value. The pit in my stomach tells me this share will break resistance next time but may have to wait for news.
View more share chat for Skinbiotherap. (SBTX) >>







Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk








Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.